THE INNER WORKINGS of major pharmaceutical companies are complex labyrinths of philosophies, regulations, strategies, plans, politics, personnel, and departments. In these labyrinths, CME is given varying levels of attention and importance. Some...
ON SEPTEMBER 28, 2004, the updated Accreditation Council for CME Standards for Commercial Support were finally approved. The new Standards were the main topic at the recent AMA Conference on CME Provider/Industry Collaboration in Baltimore. Three...
“In my company, CME is now considered too risky. We're pulling back,” said a participant at the Pharmaceutical Alliance for CME breakout session at the American Medical Association's conference on CME Provider/Industry Collaboration, held in...
What some providers say they find particularly galling about Stark II is that the Centers for Medicare and Medicaid Services' Medicaid/Medicare reimbursement policy is moving toward a “pay for performance” standard. This means that hospitals and...
FIRST, HAVE FAITH that the American Medical Association, the American Hospital Association, the Council of Medical Specialty Societies, the Alliance for CME, the Association of American Medical Colleges, and others will have the wisdom and the...
I WAS RECENTLY reminded of how to make a great first impression. This past August, I attended the Drug Discovery Technology conference in Boston. The discussions and demonstrations at the conference shape the ideas that will transform the...
THE RECENT FOCUS on outcomes research and evaluation has created a dilemma among CME providers and others involved in the process. On the one hand, most would agree that the use of electronic and traditional techniques to determine whether CME...
CME IS FOR SPECIALISTS, not primary care physicians. Commercial supporters won't fund education unless they can influence the content. That was the prevailing wisdom in Mexico — until LiveMed, a CME company that produces symposia and academic...